Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




In Vivo Multispectral Imaging System Designed to Monitor Changes in Molecular Activity

By HospiMedica International staff writers
Posted on 22 Apr 2009
A new in vivo multispectral imaging system is designed to enable researchers to precisely locate and monitor changes in molecular activity of specific areas of interest--long before morphologic changes can be detected--accelerating the development of effective therapeutics for disease treatment.

Investigators from the University of Notre Dame (South Bend, IN, USA) are using the latest in vivo and in vitro optical molecular imaging technology from Carestream Health (Rochester, NY,USA) Molecular Imaging as part of its cutting-edge research of infectious disease, bone disease, cancer, and other medical applications.

The In Vivo Imaging Core, part of the recently commissioned Notre Dame Integrated Imaging Facility (NDIIF), chose the Kodak in vivo multispectral imaging system FX for its multimodal molecular imaging needs. More...
The imaging facility utilizes the system for a range of imaging techniques including chemiluminescent, fluorescent, X-ray, and radioisotopic applications.

"The Kodak multispectral system is very popular in our core imaging facility because it offers our researchers four powerful imaging modalities in a single system, and we use them all," said W. Matthew Leevy, Ph.D., research professor and managing director of the In Vivo Imaging Core, University of Notre Dame. "Of particular value is the multi-modal capability," he added. "The system's X-ray mode provides a convenient anatomical map with which to precisely coregister and accurately localize optical or radioisotopic signals emanating from target disease cells. This is an extremely powerful and useful combination."

Notre Dame's In Vivo Imaging Facility focuses on noninvasive methods to observe and image various disease models and biologic processes in living systems. It is colocated with the Freimann Life Science Center (FLSC), which provides a full range of veterinary services. Together, the NDIIF and FLSC provide animal care and imaging services to a wide range of investigators at the University and regional levels.

Related Links:
University of Notre Dame
Carestream Health



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Morcellator
TCM 3000 BL
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.